Clinical Trial Results:
A Placebo-Controlled, Randomized, Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Neurogenic Detrusor Overactivity and Neurological Respiratory Impairment
Summary
|
|
EudraCT number |
2006-006299-39 |
Trial protocol |
NL FR |
Global completion date |
05 Dec 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Nov 2016
|
First version publication date |
03 Nov 2016
|
Other versions |
|
Summary report(s) |
CT.gov Summary Results - Study 191622-082 - Eudra 2006-006299-39 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.